19-44672869-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001127893.3(CEACAM19):c.329G>A(p.Arg110His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000308 in 1,592,996 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001127893.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM19 | NM_001127893.3 | c.329G>A | p.Arg110His | missense_variant | 2/8 | ENST00000358777.10 | NP_001121365.1 | |
CEACAM19 | NM_020219.5 | c.329G>A | p.Arg110His | missense_variant | 2/8 | NP_064604.2 | ||
CEACAM19 | NM_001389722.1 | c.329G>A | p.Arg110His | missense_variant | 3/9 | NP_001376651.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM19 | ENST00000358777.10 | c.329G>A | p.Arg110His | missense_variant | 2/8 | 1 | NM_001127893.3 | ENSP00000351627 | A2 | |
CEACAM16-AS1 | ENST00000662585.1 | n.475+26215C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000594 AC: 14AN: 235664Hom.: 0 AF XY: 0.0000706 AC XY: 9AN XY: 127408
GnomAD4 exome AF: 0.0000298 AC: 43AN: 1440708Hom.: 1 Cov.: 31 AF XY: 0.0000322 AC XY: 23AN XY: 714908
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74448
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.329G>A (p.R110H) alteration is located in exon 2 (coding exon 2) of the CEACAM19 gene. This alteration results from a G to A substitution at nucleotide position 329, causing the arginine (R) at amino acid position 110 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at